We’re transforming the paradigm for lower
extremity diabetes care

The healthcare ecosystem is changing rapidly.

The COVID-19 pandemic has created new opportunities for the use of technology to extend care into patients’ homes that is expected to continue long after the crisis is over. Payment structures are evolving from volume to value. Access to timely and appropriate care is vital to improving outcomes while reducing costs, and social determinants of health must be considered.

The traditional way of ‘doing business’ is on its way out.

The explosion of diabetes has resulted in challenges to our healthcare system and providers alike.

CLUE®, Arche Healthcare’s population health management strategy, is designed to identify, monitor and prevent avoidable complications including chronic wounds, amputation and death, while increasing quality of life and positively affecting the health literacy levels of the individual with diabetes. CLUE is built on the five standards of a lower extremity amputation prevention (LEAP) program and drives the execution of the most current clinical practice guidelines shown to reduce the risk of ulcer and amputation in patients with diabetic neuropathy by as much as 54%.

COVID-19 has particularly affected people with diabetes. They have experienced missed or delayed visits, treatments, and procedures because they were, or perhaps still are, unable to access care because healthcare facilities are limiting visits or have been closed. In other instances, members haven’t sought care because of stay-at-home orders, fear of virus exposure or emerging economic hardship. This is going to produce a tsunami of diabetic foot ulcers that will result in lower extremity amputations.

Proactive, virtual outreach to provide members at greatest risk with guideline-directed care is imperative to minimize COVID-19’s harmful effects and support health system recovery. Arche Healthcare has embraced this challenge and developed a robust population health management strategy that provides podiatrists and members with accessible channels to communicate and continue on their journey to better health and better care.

InFocus®, Arche Healthcare’s remote patient monitoring (RPM) program for the diabetic foot, provides members with tools to communicate their lower extremity health status to their podiatrist from the safety and comfort of their homes. This technology ensures the provision of high-quality care in this unprecedented time.

Arche HealthcareArche HealthcareFast Fact: Experts believe that #DiabetesCare is ideally suited to #Telehealth, since glucose readings & other data guide #DiseaseManagement – and is easily jointly reviewed and discussed by doctors and patients over #DigitalPlatforms. Check out https://t.co/KMJ8mqB8I0 #PopHealth6 days ago
Arche HealthcareArche HealthcareFast Fact: New study states #BlackPatients with type 1 diabetes mellitus (T1D) and #COVID19 are 4 times more likely to develop #DiabeticKetoacidosis than white counterparts. Learn more https://t.co/XUY3Vio58p #PopHealth #DiabetesCare1 week ago
Arche HealthcareArche HealthcareFast Fact: #CardiovascularDisease and #Type2Diabetes are companion concerns. Read more https://t.co/CvXHkVrzXW #PopHealth #DiabetesCare #CVD #T2D1 week ago
Arche HealthcareArche HealthcareFast Fact: Obesity is a major contributor to diabetes, and a new study suggests more tailored efforts are needed to reduce the incidence of obesity-related diabetes. Learn more https://t.co/9i6WCJWDqX #PopHealth #DiabetesCare2 weeks ago
Arche HealthcareArche HealthcareFast Fact: New research now includes #BrainDamage resulting from uncontrolled #T2Diabetes. Higher #HbA1c levels are associated with more significant risks of brain damage. Read more https://t.co/TmeitCUpzv #PopHealth #UncontrolledT2D2 weeks ago
Arche HealthcareArche HealthcareFast Fact: Middle-aged adults with #T2Diabetes have a disproportionate #Risk increase for #COVID19 mortality and should receive #Priority for early #Vaccination. Check out https://t.co/Z1z9CFez7n #DiabetesCare #PopHealth2 weeks ago
Arche HealthcareArche HealthcareFast Fact: Heat-stable #Insulin is a #GameChanger for people with #Diabetes. Learn more from this new study by Médecins Sans Frontières (MSF) and University of Geneva, published in the journal PLOS ONE. https://t.co/j6ZLbIa8M8 #PopHealth #DiabetesCare3 weeks ago
Arche HealthcareArche HealthcareFast Fact: New study states #Metformin was associated with a threefold decrease in #COVID19 #Mortality for people with #Diabetes independent of glucose profile and BMI. Read more https://t.co/Pb9wszkJwm #DiabetesCare #PopHealth3 weeks ago
Arche HealthcareArche HealthcareFast Fact: #LowerExtremity #ArterialThrombosis is a possible complication of #COVID19 infection and early diagnosis is crucial for #LimbPreservation in #LowerExtremityIschemia. Check out https://t.co/4m9zKEx7HO #DiabetesCare #PopHealth3 weeks ago
Arche HealthcareArche HealthcareFast Fact: Patients may have individual preferences for certain #DiabeticCare practices; as a result, assessing #PatternsOfPractices at the individual and overall level is valuable. Check out https://t.co/zcJ8l0pEXP #PopHealth4 weeks ago
Do More
Be More
Learn More

Arche OPTYX

Do you have a system that helps you automate documentation, improve patient outcomes and increase reimbursements simultaneously? The Arche LEAP Collaborative has developed the Arche OPTYX system which supports processes and protocols that will enable you transform into an insights-driven organization that has successfully turned evidence-based medicine into evidence-based practice while seamlessly meeting Medicare documentation requirements.

Our analytics capability leverages disparate data sources that enables you to monitor your progress toward targets and offers you information on your performance compared to the rest of the Arche LEAP Collaborative. As a result, you will be able to transform your practice into an insights-driven organization.

Arche LEAP Collaborative (ALC) Practice Registration

Let’s begin. The first step is to register and enroll in the Arche LEAP Collaborative. You can do this through the Take the LEAP link at archehealthcare.com. You will need an access code. If you don’t have one, you can let us know about your interest through the "Let’s Talk" link at archehealthcare.com or by speaking to the person who told you about the Arche LEAP Collaborative.

Populate and Update Practice Dashboard and Diabetes Patient Registry

When you join the Arche LEAP Collaborative, we will gather information from your EHR system through an automated process to create a registry of patients with diabetes. Arche OPTYX will identify patients who should have an Arche CDFE (Comprehensive Diabetic Foot Exam), patients who have or have had wounds and amputations and it will also help you manage therapeutic footwear and insole prescriptions.

Training for Arche LEAP Captain

Training is essential to success and having a designated Arche LEAP Captain is an essential element of a successful program. The Arche LEAP Captain is the owner of the Arche LEAP Collaborative program in your practice. Arche LEAP Captains go through extensive training where they learn about the impact of diabetes on the lower extremities, techniques to educate patients on how to care for their feet and the protocols and processes of the Arche LEAP Collaborative program. To ensure LEAP Captains have effectively completed the necessary training, an evaluation of their proficiency as a Therapeutic Footwear Specialist is required at the conclusion of the training program.

Schedule CDFE Appointment

Once identified, patients who need an Arche CDFE should be scheduled for an appointment. All patients with diabetes should have one Arche CDFE per year.

Arche CDFE

We think of the Arche CDFE as more than just a clinical exam. For us, the CDFE should be a Comprehensive Diabetic Foot Experience! Using our tools and processes turns a clinical examination into an experience that improves your patient’s health literacy by illustrating their personal risk and in response, teaching them best practices for self-care. This proactive approach leads to the prevention of ulcers and amputations.

Rx Documentation Procurement and Review

We make documentation easy! From the patient’s signature on a Release of Information authorization to the final Dispensing Package, the entire CDFE exam and process is managed through the Arche OPTYX program.

As documents are gathered, an ongoing review is conducted to ensure that all CMS requirements for completeness are met. We follow-up with the MD/DO managing the patient’s diabetes up to eight (8) times in an effort to assemble a complete documentation packet that will pass an audit. When all of the documentation is gathered and found to be satisfactory, the prescription is sent to be filled.

If there is an audit, all of the required documentation will be available in one place so that you can easily print or upload it to the requestor.

Rx Dispensed

All of the required documents for the fitting and dispensing appointment reside in Arche OPTYX.

During the appointment, the Arche LEAP Captain uses their training to ensure proper footwear and insole fit and introduces home monitoring to the patient.

When the appointment is completed, all of the documentation is reviewed by the Documentation Team for thoroughness and accuracy. When correct and complete, the Dispensing Packet will be added to the rest of the documentation, and the prescription procurement packet will be complete.

Home Temperature and Moisture Monitoring

Arche Healthcare offers you the opportunity to provide your patients with an easy to use device to measure their Skin Moisture Index and an FDA approved at-home plantar temperature monitoring device that enables them to engage in their own self-care.

Patient Follow-up calls and texts

You are the front line for the care of the lower extremities of your patients with diabetes, and we want to ensure that they come back when they need to!

OPTYX will remind the ALC to call patients two weeks after they have had their therapeutic footwear and insole prescription dispensed. It will also text those that choose to participate in the ReCare program to remind them to come in for their annual CDFE, and for those that are eligible, to come in for their at-risk foot care appointments. Your ALC will also be provided with a list of patients to call who have not had a CDFE in the past year or longer so that your team can call and schedule them for their appointment.

Manage your outcomes

OPTYX equips healthcare providers and relevant healthcare stakeholders with the necessary tools to systematically identify and stratify patients with diabetes to reduce their risk for developing life-threatening diabetic foot complications. It is a patient and prescription management system that tracks and calculates adherence to protocols by each physician, each practice and the entire ALC.

When your registry of patient with diabetes is created, their prior history of wounds, amputations and footwear prescriptions is gathered. Outcomes are measured by comparing a two-year pre-program baseline with the incidence of wounds and amputations going forward. We will also track CDFE’s, at-risk foot care and footwear and insole prescriptions.